Format

Send to

Choose Destination
Oncotarget. 2017 Aug 8;8(43):75411-75417. doi: 10.18632/oncotarget.20034. eCollection 2017 Sep 26.

Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies.

Author information

1
Department of Epidemiology, Richard M. Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202-2872, USA.
2
Department of Dermatology, Stanford University School of Medicine, Stanford, CA 94063, USA.

Abstract

BACKGROUND:

Existing evidence of the association between statin use and non-melanoma skin cancer (NMSC) risk has been inconsistent.

OBJECTIVE:

To maximize statistical power to synthesize prospective evidence on this relationship.

MATERIALS AND METHODS:

PubMed, EMBASE, Web of Science, Cochrane Central Register of Controlled Trials, and ClinicalTrial.gov were systematically searched up to December 11, 2016. A random-effects meta-analysis was conducted to calculate summary estimates.

RESULTS:

Our meta-analysis of 14 randomized controlled trials (RCTs) including 63,157 subjects showed no significant association between statin use and NMSC risk (RR = 1.09, 95%CI = 0.85-1.39). However, meta-analysis of four observational studies including 1,528,215 participants showed significantly increased risk of NMSC among statin users compared to non-users (RR = 1.11, 95%CI = 1.02-1.22). Furthermore, ever using lipophilic statins (RR = 1.14, 95%CI = 1.04-1.24) or lower-potency statins (RR = 1.14, 95%CI = 1.03-1.26), as well as usage of any statin longer than one year (RR = 1.14, 95%CI = 1.09-1.18) were significantly associated with increased NMSC risk based on observational studies.

CONCLUSIONS:

Evidence from observational studies supported an association between statin use and increased NMSC risk. This finding should be interpreted with caution due to modest number of included studies, possible between-study heterogeneity and inherent limitations of observational studies.

KEYWORDS:

meta-analysis; non-melanoma skin cancer; statins

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center